Last updated 2026-07-26
Total raised
—
Last: Undisclosed Round 2024-07
Stage
Series C
Founded
2000
Headcount
20
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
NanoPass Technologies is an Israeli company that develops innovative, safe, and efficient platforms for intradermal delivery of vaccines, therapeutics, and aesthetic products. Their proprietary MicronJet™ platform leverages MEMS (Micro Electro Mechanical Systems) technology to provide precise, minimally invasive, and virtually pain-free injections. The company's products are supported by extensive clinical data and global regulatory approvals, aiming to enhance clinical outcomes, improve patient compliance, and set new standards in healthcare delivery.
Headcount over time
20 employees (2026-09) · 1 point
Offices
Ness Ziona, Israel · HQ / main office
Q&A
- What is NanoPass Technologies' primary focus?
- NanoPass Technologies is an Israeli company that develops innovative, safe, and efficient platforms for intradermal delivery of vaccines, therapeutics, and aesthetic products, utilizing their proprietary MicronJet™ platform.
- When was NanoPass Technologies founded?
- NanoPass Technologies was founded in April 2000.
- How many employees does NanoPass Technologies currently have?
- NanoPass Technologies has 11–50 employees.
- What is the total amount of funding NanoPass Technologies has raised to date?
- NanoPass Technologies has raised a total of $18,900,000 in funding.
- What is NanoPass Technologies' current funding stage?
- NanoPass Technologies is currently in the Series C funding stage.
- What is a key product offered by NanoPass Technologies?
- NanoPass Technologies offers the MicronJet™ platform, which leverages MEMS technology for precise, minimally invasive, and virtually pain-free intradermal injections.
- What was a significant product launch announcement for NanoPass Technologies?
- In January 2026, NanoPass Technologies will officially launch MicronJet™ 800 during IMCAS World 2026, expanding its product portfolio for intradermal delivery.
Team · 13
Dr. Shuki Yeshurun
Founder · Founder
Daniel Levitats
CEO
Dr. Yotam Levin
President of Innovation
Dr. Efrat Kochba
VP Medical Affairs
Tal Shlezinger
VP Sales and Marketing
Yoav Hamisha
VP of Product Development & Operations
Ayala Kamil
VP QA/RA
Yafit Keret
VP Finance
Marvin Samson
Board Member
Dr. Scott Young
Board Member
Yaron Ashkenazi
Board Member
Osher Shapira
Board Member
Gal Admati
Chief Operating Officer
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesSilicon
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
cosmeticsmedical-equipmentdiabetespharma-companiesdrug-deliverymedical-technologiespain-freedoctorshospitalshealthcare-providersvaccinesnanotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
Identifiers & details
| Legal name | NanoPass Technologies Ltd. |
|---|---|
| Founded | 2000-4 |
| Employees (exact) | 20 |
Radar intelligence
Patents
| EPO | 36 |
|---|
Web history (Wayback)
| Domain | nanopass.com |
|---|
Certificate / subdomain footprint
| Subdomains | 16 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512936212 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2000-04-04 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 6 — people (3), other (1), violation (1), shares_capital (1) |
| Registered address | גולדה מאיר 3 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-31 | עדכון דירקטורים-הסרת דירקטור |
| 2026-05-27 | עדכון דירקטורים-הוספת דירקטור |
| 2026-05-26 | שינוי בתקנון |
| 2026-06-25 | עדכון הפרה |
| 2025-08-14 | עדכון בעלי תפקידים |
| 2026-02-11 | הקצאת מניות |